Patent · US Active

Substituted nucleotide analogs

US9605018B2 · kind B2 · utility

46Cited by
153References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2015
Grant dateMar 28, 2017
Priority date—
Expiry dateAug 9, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/207
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.